Oncology Data Advisor

Targeting p53 in the Treatment of Hematologic Malignancies With Matthew Davids, MD, MMSc

Informações:

Synopsis

Tumor suppressor gene p53 is the most frequently mutated gene in human malignancy. Through a complex series of molecular events, p53 leads to malignant cell proliferation and plays a significant role in tumor formation. In this interview with Oncology Data Advisor, Dr. Matthew Davids of Harvard Medical School delves further into the latest research in p53-directed therapeutic strategies and the future of targeting this specific mutation.